# Sabra Health Care (SBRA) — Earnings

SBRA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sbra/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.10 |
| EPS estimate | $0.17 |
| EPS surprise | −158.45% |
| Revenue surprise | +7.51% |
| Revenue | $235.9M |
| Revenue estimate | $219.4M |
| Reported | Aug 3, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1492298/000149229826000028/sbra-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/94ea55d0-d840-ce30-84bc-6ae16aee7f4e.html) |

Sabra Health Care reported Q2 2026 results on August 3, 2026. It posted a loss of $0.10 per share against an estimated profit of $0.17, a miss of 158.45%. Revenue was stronger: $235.9 million, 7.51% above the $219.4 million consensus and about 25% above the $189.2 million of Q2 2025. A year earlier, Sabra earned $0.27 per share, its highest quarter in the table.

Revenue has risen steadily over the last 20 quarters, from $128.6 million in Q3 2021 to the latest quarter's high, an increase of about 83%. EPS has been far more uneven. Annual EPS was a loss of $0.34 in 2022, then $0.05 in 2023, $0.53 in 2024 and $0.64 in 2025. The first half of 2026 totaled $0.06. Six of the 20 quarters were losses, the deepest a loss of $0.37 per share in Q4 2022. Sabra topped EPS estimates only three times in this period, most recently in Q2 2025.

Q3 reports have come between October 31 and November 7 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether earnings return to a profit while revenue keeps growing.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 3, 2026 | $0.17 | −$0.10 | -158.45% | $219.4M | $235.9M |
| Q1 2026 | Apr 29, 2026 | $0.16 | $0.16 | -0.87% | $209.2M | $221.8M |
| Q4 2025 | Feb 12, 2026 | $0.16 | $0.11 | -32.97% | $198.0M | $211.9M |
| Q3 2025 | Nov 5, 2025 | $0.18 | $0.09 | -50.93% | $186.8M | $190.0M |
| Q2 2025 | Aug 4, 2025 | $0.17 | $0.27 | 54.73% | $180.9M | $189.2M |
| Q1 2025 | May 5, 2025 | $0.17 | $0.17 | -1.96% | $179.0M | $183.5M |
| Q4 2024 | Feb 19, 2025 | $0.16 | $0.19 | 16.35% | $178.4M | $182.3M |
| Q3 2024 | Oct 31, 2024 | $0.16 | $0.13 | -17.04% | $172.7M | $178.0M |
| Q2 2024 | Aug 7, 2024 | $0.15 | $0.10 | -32.84% | $166.5M | $176.1M |
| Q1 2024 | May 8, 2024 | $0.14 | $0.11 | -20.52% | $160.4M | $166.7M |
| Q4 2023 | Feb 27, 2024 | $0.13 | $0.07 | -47.96% | $162.9M | $163.4M |
| Q3 2023 | Nov 6, 2023 | $0.13 | −$0.07 | -153.85% | $160.3M | $161.6M |
| Q2 2023 | Aug 7, 2023 | $0.09 | $0.09 | -3.54% | $158.7M | $161.2M |
| Q1 2023 | May 3, 2023 | $0.12 | −$0.04 | -134.78% | $159.1M | $161.3M |
| Q4 2022 | Feb 21, 2023 | $0.13 | −$0.37 | -389.06% | $154.1M | $165.0M |
| Q3 2022 | Nov 7, 2022 | $0.16 | −$0.22 | -234.72% | $154.3M | $140.8M |
| Q2 2022 | Aug 3, 2022 | $0.16 | $0.07 | -55.70% | $156.1M | $156.0M |
| Q1 2022 | May 4, 2022 | $0.15 | $0.18 | 17.72% | $153.0M | $163.1M |
| Q4 2021 | Feb 22, 2022 | $0.13 | −$0.11 | -182.21% | $150.1M | $135.7M |
| Q3 2021 | Nov 3, 2021 | $0.14 | $0.05 | -63.85% | $151.6M | $128.6M |

## Frequently Asked Questions

### When did Sabra Health Care (SBRA) last report earnings?

Sabra Health Care last reported on Aug 3, 2026, covering fiscal Q2 2026.

### Did SBRA beat earnings estimates?

No. Sabra Health Care reported EPS of −$0.10 for Q2 2026 against a $0.17 estimate — a 158.45% miss.

### How much revenue did SBRA report last quarter?

Sabra Health Care reported $235.9M in revenue for Q2 2026, against a consensus estimate of $219.4M.

## Similar Stocks

- [OHI](https://www.lighthorse.io/tickers/ohi) — Omega Healthcare Investors, Inc. Common Stock
- [CTRE](https://www.lighthorse.io/tickers/ctre) — CareTrust REIT, Inc. Common Stock
- [NHI](https://www.lighthorse.io/tickers/nhi) — National Health Investors, Inc. Common Stock
- [LTC](https://www.lighthorse.io/tickers/ltc) — LTC Properties, Inc. Common Stock
- [VTR](https://www.lighthorse.io/tickers/vtr) — Ventas, Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).